How To Avoid Confirmation Bias In Investing

Psychological biases are the human tendency for us to make decisions in an illogical way. The concept was introduced by psychologists Daniel Kahneman, Paul Slovic, and Amos Tversky in the early 1970s. Kahneman later won a Nobel Prize for his work and went on to write the best-selling book Thinking, Fast and Slow.

In his book, Kahneman describes the “fast thinking” part of the brain as System 1. This way of thinking helps us make snap decisions, such as jumping away when we hear a loud noise.

Slower thinking, or System 2, is used to solve more complicated problems. Usually, Systems 1 and 2 work very well, but in some situations, System 1 may cause a person to jump to conclusions too quickly and lead to what we now know as psychological biases.

What is confirmation bias?

There are numerous psychological biases and one of the more common and well-known of them that affects us as investors is confirmation bias. Confirmation bias is our tendency to cherry-pick information that supports our existing beliefs.

It partly explains why two people with opposing views can come to very different conclusions when they see the same piece of information. It can also cause us to make bad investing decisions. Take the scenario below for an example.

A friend at a party whispers a hot investing tip to you. You get excited at the prospect of making money but realise that it is important to do your own research. When you reach home, you hastily search for more information. Unfortunately, because of your preconceived conception of the company, you unwittingly reject data that goes against your belief and only look for information that supports it. Thinking you did sufficient due diligence, you make your trade the next day.

This is a common phenomenon. You’ll be surprised how easy it is to interpret data and statistics to fit your preexisting view.  Shane Parish, in his Farnam Street blog, wrote:

“Confirmatory data is taken seriously, while disconfirming data is treated with scepticism.”

In his book, Six Thinking Hats, Edward De Bono wrote:

“There may be more danger in prejudices which are apparently founded in logic than in those which are acknowledged as emotions.”

Why do we suffer from confirmation bias?

If the above scenario sounds familiar, then you have suffered from confirmation bias.

There is an innate desire for us to want to have been right. In the book The Web of Belief, authors Willard V Quine and J.S Ullian wrote,

“The desire to be right and the desire to have been right are two desires, and the sooner we separate them the better off we are. The desire to be right is the thirst for truth. On all counts, both practical and theoretical, there is nothing but good to be said for it. The desire to have been right, on the other hand, is the pride that goeth before a fall. It stands in the way of our seeing we were wrong, and thus blocks the progress of our knowledge.”

Confirmation bias is so ingrained in our brains that knowing that we tend to suffer from confirmation bias is not enough. The act of seeking out other data is not the solution- the problem is not being open to an alternative view.

How do we overcome it?

The first thing we should do is to give ourselves time to make a decision. Giving ourselves time to conduct research, talk to people in the know, and look for a different point of view, can reduce the risk of confirmation bias. Darren Matthews wrote in an article:

“It seems logical to add time to making decisions, slowing things down. Time offers a perspective that brings with it the capacity to bring other steps into play.”

Second, actively search out opposing views. Find arguments that reject your initial view and dig into the other corner of the Internet. Further, be willing to change your opinion if you find sufficient evidence to do so. 

Third, acknowledge that changing our opinion can be extremely difficult. In The Little Book of Stupidity, Sia Mohajer wrote:

“Research has shown that attempts to “enlighten” believers can be either entirely useless or serve to bolster their current belief systems. This bolstering of belief is often referred to as entrenching. This is the idea that once you have invested mental energy into a habit or belief, you strongly reject any potential contradictory information.”

We, therefore, have to make a conscious effort to realise the challenge we face in changing our opinion.

Final words

“What the human being is best at doing is interpreting all new information so that their prior conclusions remain intact.”

Warren Buffett

Confirmation bias is part of our everyday life. It affects anything from our political views to our religious beliefs to our investing decisions.

The first step to overcoming confirmation bias is to acknowledge that it affects us. Only then can we take active steps to have safeguards to ensure that it does not negatively impact our lives – or in this case our investment returns.

DisclaimerThe Good Investors is the personal investing blog of two simple guys who are passionate about educating Singaporeans about stock market investing. By using this Site, you specifically agree that none of the information provided constitutes financial, investment, or other professional advice. It is only intended to provide education. Speak with a professional before making important decisions about your money, your professional life, or even your personal life.

What Causes Share Prices to Increase?

Share price appreciation and dividends are the primary drivers of returns for shareholders.

In an earlier article, I discussed how stock prices are a function of future cash flows to the investor. In much the same light, investors sometimes value stocks based on multiples to earnings or revenue. This is because revenue and earnings is what ultimately drives cash flow to shareholders.

In this article, I discuss how business fundamentals and valuation growth may drive capital appreciation.

The two key factors

The equation below shows the relationship between share price appreciation, valuation, and a company’s growth.

Share price appreciation = Earnings/revenue growth X Price-to-earnings/revenue multiple expansion

Put simply, a company’s share price is driven by earnings/revenue growth and changes in the price-to-earnings/revenue multiple.

Increases in the price-to-revenue/earnings multiples are usually driven by a better outlook, new information, or market participants appreciating a company’s future prospects.

How to use this information?

As investors, knowing how stock prices rise can help us to pick stocks.

The sweet spot is to find a company that will grow its earnings/revenue and is also likely to experience valuation-multiple growth. 

But companies that can grow revenue/earnings at a quick pace without a valuation multiple expansion can still serve investors very well. For example, a company that is growing earnings at 20% per year, and does not experience a valuation compression, will give shareholders capital appreciation of 20% per year.

Too often, investors focus on the second part of the equation, hoping that valuation-multiple expansion can drive stock price appreciation, without taking into account that business performance also drives stock price performance.

In fact, even if there is a valuation compression, a company can still be a good investment if revenue or profit grows faster than the valuation squeeze. To illustrate this, I came out with a simple example. Let’s assume Company ABC grows revenue at 70% per year but is expensively priced at 60-times sales. 

The table illustrates what happens to ABC’s share price if there is a valuation compression each year.

Source: My computation

As you can see, ABC’s share price grew a decent 25% per year despite the price-to-sales multiple dropping from 60 to 30. The above example can give us perspective on what we are experiencing in today’s investing environment.

There are numerous technology companies that are growing at a triple or high double-digit pace, and are expected to grow at these rates for the next few years At the same time, their price-to-revenue multiples are so high that is it likely the multiple will fall over the years. But if the top-line can grow faster than the contraction in the valuation multiple, we will still see the shareholders of these companies be handsomely rewarded.

Risks to growth

Before you invest in any richly-priced stock, you must know that high valuation multiples also pose a risk. If a company cannot grow revenues or profits as fast as its valuation contracts, its stock price may fall off a cliff. 

As such, investors need to be mindful that a rich valuation also comes at a cost. Valuation contraction can be extremely painful for investors if the company does not live up to the kind of growth that the market is expecting of it.

Final words

Deep value investors tend to focus on the second part of the equation, hoping that the market will realise that a company’s valuation multiple is too low – when the market becomes aware of its folly, the valuation multiple could expand, which could lead to stock price growth.

But don’t underestimate the importance of the first part of the equation- business growth. This is ultimately the longer-term determinant of a company’s share price. Valuation multiples can only expand up to a certain point before the expansion becomes unsustainable, while business growth can continue for years. Business growth can lead to huge stock price appreciation and is to me, the best way to find multi-baggers over the long term.

Disclaimer: The Good Investors is the personal investing blog of two simple guys who are passionate about educating Singaporeans about stock market investing. By using this Site, you specifically agree that none of the information provided constitutes financial, investment, or other professional advice. It is only intended to provide education. Speak with a professional before making important decisions about your money, your professional life, or even your personal life.

How Future Dividends Drive Capital Growth in Stocks

What do we get when we buy a stock? In simplified terms, we are paying upfront for the rights to receive its future dividends.

The ultimate goal of investing is simply to make money.

The art of picking good investments is complicated but it boils down to one key question: What is the future cash investors can generate from an asset today? If we invest in real estate, rental income and resale value will determine our investment returns. For bonds, the cash flow is derived from coupons and the redemption value at maturity. Similarly, when we buy a stock it gives us the right to earn a stream of dividends in the future.

Companies that don’t pay dividends

But what if a company does not pay dividends? A famous example is Warren Buffet’s Berkshire Hathaway, which has only paid a dividend once since Buffett took over in 1965. Why then would a shareholder buy such a company if he is not going to earn any dividends from it? 

The answer, though, still boils down to dividends. Shareholders believe that eventually, Berkshire will start paying them dividends. This, in turn, makes the company’s shares valuable so that it can then be sold to another investor.

I’ve drawn up a simple example to explain this.

Let’s assume Company ABC can earn $10 per share in year 1. From year 1 to year 10, it reinvests its entire profit and does not pay any dividend. During this time, it grows its profit by 30% per year. 

From year 11 to year 20, it pays out 50% of its profit and reinvests the other 50% and grows its profits by 15% per year.

Eventually, in year 21, the company has run out of ways to grow its profits and decides to payout 100% of its profits to shareholders. It is able to earn this level of profit till eternity.

The table below shows how the value of the company changes over time based on the discounted dividend model.

Source: My calculation

I used a discount rate of 10% to calculate the value of the future dividend stream to the shareholder. As you can see, even though the company did not pay out any dividends in year 1, its shares still had value due to the promise of future dividends starting from year 11. The company’s share price grew as we got closer to the dividend-paying years.

As a result, even though shareholders in the first 10 years did not earn a cent in dividends, they still made money through capital gains.

From this example, we see the value of the company grows as the discount rate for the future cash flow decreases the closer we get to the dividend-paying years.

In addition, a company’s market value can also rise if there is an unexpected increase in earnings that results in a higher potential dividend.

Final words

Investing is ultimately about the future cash flow an investment brings for the investor.

In the case of stocks, it all boil down to dividends. Even capital appreciation is driven by (1) growth in dividends and (2) the smaller discount we apply to future dividends as the dividend stream draws closer.

Disclaimer: The Good Investors is the personal investing blog of two simple guys who are passionate about educating Singaporeans about stock market investing. By using this Site, you specifically agree that none of the information provided constitutes financial, investment, or other professional advice. It is only intended to provide education. Speak with a professional before making important decisions about your money, your professional life, or even your personal life.

Should We Wait For a Market Pullback?

Are you waiting for the stock market to pull back? Here are some thoughts on market timing and why I prefer to be always invested.

Just a glance at the price chart of a stock market index will tell you that stocks don’t go up in a straight line. Stocks go up in a zig-zag pattern, making peaks and troughs.

Wouldn’t it be wonderful if we could keep buying at troughs and selling at peaks? We’d all be extremely rich. But the reality is it’s impossible. Even the best investors will tell you that timing the market perfectly is a pipedream. Yet, time and again, I still hear novice investors who are trying to do exactly that.

“The market looks expensive now. Maybe I should wait for another day.”

This statement may seem innocuous and something that many investors are feeling now. It is also understandable. The S&P 500 in the US fell by more than 30% from 19 February 2020 to 23 March 2020, but has since recovered almost all of the losses. Meanwhile, COVID-19 cases continue to surge and lockdowns are still imposed in many parts of the world.

I’m not saying that I know for a fact that stocks will keep rising from here. However, trying to time the market over the long-term will likely do you more harm than good. According to asset management firm Franklin Templeton, missing just a few of the stock market’s best days will severely damage your returns:

Source: https://www.franklintempleton.com/forms-literature/download/GOF-FL5VL

Staying fully invested over the 20 years leading up to December 2019 would have given you a 6.06% total annual return. However, miss just the best 10 days and your return would fall to only 2.44% per year. Miss the best 20 days, and your return drops to a negligible 0.08%. Miss the 30 best days and you are looking at a -1.95% annual loss. That would be 20 wasted years of investing.

I can draw one simple conclusion from this: The risk of staying out of the market is huge. Because of this, I much prefer a way less risky, albeit boring, approach of staying invested. By doing this, I know that I will not risk missing out on the best trading days of the market.

Less stress

Timing the market is also extremely stressful. Even for investors who are able to get it right once in a while, do the extra returns justify the effort? You’ll need to constantly monitor the market, find opportunities to buy and sell and are likely to still end up messing things up (see above).

Imagine you sold your investments just before some of the best trading days occur and the index/stock you are investing in never goes back to where you sold it at. You’d have missed out on some gains.

And what would you do next? Would you be able to convince yourself to buy back in at a higher price than you sold? You will likely continue compounding your mistake by never investing again. That’s a big mistake as historically the stock market tends to keep making new highs.

Final words

Time is your greatest friend in investing. There will always be reasons not to invest in the market. 

The legendary investor Peter Lynch once said that “Wall Street makes its money on activity; you make your money on inactivity.” Investors who are tempted to time the market should remember these wise words.

Disclaimer: The Good Investors is the personal investing blog of two simple guys who are passionate about educating Singaporeans about stock market investing. By using this Site, you specifically agree that none of the information provided constitutes financial, investment, or other professional advice. It is only intended to provide education. Speak with a professional before making important decisions about your money, your professional life, or even your personal life.

Is It Too Late To Invest in Stocks Now?

We are in a recession yet the S&P 500 has bounced strongly since March 2020. Why is this and does that mean stocks are overvalued now?

The S&P 500 index continues to defy gravity even as COVID-19 cases rise in the US. 

Investors whom I’ve been talking to are understandably getting nervous. Will the S&P 500 eventually come crashing down to reflect the recession the world is living in?

Distinguishing the S&P 500 index from the economy

The first thing I want to point out is that the S&P 500 is not an accurate representation of the US economy.

The S&P 500 represents a basket of 500 of the biggest companies listed in the US. Although it may be tempting to assume that this basket of stocks should rise and fall in tandem with the whole economy, reality looks different.

There are 32 million businesses in the US, so the S&P 500 is just a fraction of this. In addition, the S&P 500 is a market-cap-weighted index that is heavily weighted toward just a few big firms such as Apple, Amazon, Alphabet, and Facebook. These mega-cap tech companies have arguably thrived during the COVID-19-induced lockdown.

Amazon, for example, had a big jump in sales due to the need for social distancing. Facebook double-downed on investing its spare cash. With so much cash on their balance sheets, these tech giants can find bargains at a time when other businesses are struggling for cash.

If these mega caps rise in value, it can positively skew the S&P 500.

But should we invest at all-time highs?

Another concern is whether we should invest at all-time high prices? The reality is that the S&P 500 reaching new all-time high prices is actually not that uncommon.

Engaging-data.com has some interesting data related to this topic. Between 1950 to 2019, there were a total of more than 17,000 trading days. Of which, the S&P 500 reached an all-time high on 1,300 days. Interestingly, if you invested on days after the S&P 500 reached all-time highs, you’d be doing just as well as if you invested on any other day.

The chart below compares your returns if you bought at all-time high (ATH) prices vs if you bought at any other time.

Source: engaging-data.com

If you bought the S&P 500 the day after it hit a new high, your mean return over five years was 53.7%. If you bought on any other time, your mean return was 50.0%. I checked the 10-year return data, and the numbers point to the same conclusion. The mean return after 10 years, if you bought at a high, was 103.2% compared to 114.7% if you bought on all trading days.

The data shows that investing during new market highs, contrary to popular belief, gives you very similar returns to if you invested at any other time.

If this is a market peak?

But what if this market high is a peak and stocks do come crashing down after this? In this case, your returns will most likely not be as good as if you invested before or after the crash. However, that doesn’t mean you will have poor returns per se.

Ben Carlson, a respected financial blogger and wealth manager wrote an insightful piece in 2014 on investing just before a market crash. 

In his article, Carlson wrote about a fictional investor who somehow managed to time his investments at all the worst times over a 40-year period. The investor invested in the S&P 500 just before the crash of 1973, before Black Monday of 1987, at the peak of the tech bubble in 1999, and at the peak before the start of the Great Financial Crisis of 2008.

Though this frictional investor was a terrible market timer, he was a long-term investor and never sold any of his positions. Despite his terrible luck in market timing, he ended up making a 490% return on his investment over his 40-year investing period.

This goes to show that even if you invest just before a crash, stocks tend to rebound and will eventually reach new peaks.

Final Takeaways

There are a few takeaways here:

  1. It may be scary to invest in the stock market when it is at an all-time high. It is especially scary when the economy is in a recession, as we are seeing today. However, the S&P 500 is not the economy. 
  2. Not all companies have businesses that live or die by the broad economy. Some thrive during times of crisis and investing in these “anti-fragile” companies can pay dividends down the road.
  3. Whether the S&P 500 is at an all-time high or not shouldn’t make a difference to a long-term investor. The stock market tends to keep making new highs
  4. Even if stocks were to fall dramatically tomorrow, if the past is anything to go by, investing in a broad index like the S&P 500 over the long-term will still provide a very decent return over a sufficiently long investing period.

Disclaimer: The Good Investors is the personal investing blog of two simple guys who are passionate about educating Singaporeans about stock market investing. By using this Site, you specifically agree that none of the information provided constitutes financial, investment, or other professional advice. It is only intended to provide education. Speak with a professional before making important decisions about your money, your professional life, or even your personal life.

The Dark Side of Commission-Free Trading

Commission-free trading is great for the long-term investor. However, it also leads to more frequent trading, which may lead to poorer results.

Commission-free trading has skyrocketed in popularity in the US. Pioneered by Fintech startup, Robinhood, commission-free trades has revolutionised the world of investing there.

It removes the frictional cost of investing in stocks and ETFs, making investing accessible to anyone and everyone. 

For long-term investors, commission-free trading is great. Zero trading fees mean higher returns. It also “democratises” trading such that anyone, even those with a few hundred dollars to spare, can start investing in a diversified portfolio.

But what’s the catch?

Although is it hard to argue with the obvious benefits of commission-free trading, there’s a catch: It creates short-term trading behaviour.

In the stock markets, there’s data to show that long-term investors tend to do better than those who move in and out of the market.

Investors are traditionally bad market timers and tend to buy during a market peak and sell at a market bottom. This short-term trading mindset has caused retail investors to often lag the overall market, far under-performing investors who simply bought to hold.

Encourages poor trading behaviour

Just because something is free, does not mean we should be doing more of it. This is the case for trading. 

Unfortunately, the rise of commission-free trading platforms has created more short-term trading mindsets. People trade frequently just because it doesn’t cost them anything. So while investors save money on trading fees, their investment returns suffer due to poor investing behaviour.

In the book Heads I Win, Tails I Win: Why Smart Investors Fail and How to Tilt the Odds in Your Favor, financial journalist Spencer Jakab discussed how poor investor behaviour led to poor returns, even though the underlying asset performed well. An interesting example he gave was the case of the Fidelity Magellan Fund managed by legendary investor Peter Lynch. Even though the fund earned around 29% per year during Lynch’s tenure as manager of the fund from 1977 to 1990, Lynch himself estimated that the average investor in his fund made only 7% per year. This was because when he had a setback, money flowed out and when there was a recovery, money flowed in, having missed the recovery.

Good investing behaviour is the most important factor to improve long-term returns

Commission-free trading is undoubtedly a good thing for investors who are able to stick to the long-term principle of investing. However, for those who are tempted to trade more often due to the zero trading fees, commission-free trading may end up doing more harm than good.

Disclaimer: The Good Investors is the personal investing blog of two simple guys who are passionate about educating Singaporeans about stock market investing. By using this Site, you specifically agree that none of the information provided constitutes financial, investment, or other professional advice. It is only intended to provide education. Speak with a professional before making important decisions about your money, your professional life, or even your personal life.

Pain Is Part And Parcel of Long Term Investing

Investing in the stock market is not always sunshine and butterflies. Steep draw downs happen. But learning to endure pain can be hugely rewarding.

Much ink has been spilt about the great benefits of investing in the stock market. We constantly read about the power of compounding, how investing in stocks can help you beat inflation and the beauty of passive income from dividends.

But there’s a flip side to all this. Stock prices will fall every so often.

The size of the drawdowns can be big and they can happen frequently. It’s inevitable and will always be part and parcel of the stock market. 

That’s what makes long term investing so hard

Fundsmith is the UK’s largest fund by assets under management and also one of the country’s top-performing funds. Its annualised return since inception (from November 2010 to May 2020) is 18.2%, compared to the MSCI World Index’s gain of 11.2% per year.

Its investment philosophy is summed up by three simple but profound investing principles: (1) Buy good companies, (2) Don’t overpay, and (3) Do nothing.

But Fundsmith is quick to point out that though their investment philosophy may sound easy, it is anything but. In fact, Fundsmith says that the most difficult part is following its third principle – doing nothing.

As investors, we are so caught up in the day-to-day commentary about the market that doing nothing to your portfolio is so mentally difficult. One of the reasons why this is so because investors tend to try to avoid pain as much as possible. It’s human nature.

Infants enter the world with a natural instinct to avoid pain. Think of the time you touched a hot surface, and immediately retracted your hand. This is just one example of our bodies reacting to pain. 

In his book Thinking Fast and Slow, Daniel Kahneman refers to our instinct of avoiding pain as System 1 thinking, which is the automatic and fast-thinking part of the brain. But this instinct, though very useful in certain situations, can cause us to make very bad decisions in the stock market. Instead, we should force ourselves to think logically and more in-depth when it comes to investing, using the slow, logical thinking part of the brain- what Kahneman terms System 2.

Our human tendency to avoid pain

In his recent article Same As It Ever Was, Morgan Housel writes: 

“There are several areas of life where the best strategy is to accept a little pain as the cost of admission. But the natural reaction is to say, “No, no, no. I want no pain, none of it.”

The history of the stock market is that it goes up a lot in the long run but falls often in the short run. The falls are painful, but the gains are amazing. Put up with one and you get the other.

Yet a large portion of the investing industry is devoted to avoiding the falls. They forecast when the next 10% or 20% decline will come and sell in anticipation. They’re wrong virtually every time. But they appeal to investors because asking people to just accept the temporary pain of losing 10% or 20% – maybe more once a decade – is unbearable. The majority of investors I know will tell you that you will perform better over time if you simply endure the pain of declines rather than try to avoid them. Still, they try to avoid them.

The upside when you simply accept and endure the pain from market declines is that future declines don’t hurt as bad. You realize it’s just part of the game.”

Opportunities created

Yet, it is this same aversion to pain that creates opportunities in the stock market. My blogging partner, Ser Jing, wrote in an article of his:

“It makes sense for stocks to be volatile. If stocks went up 8% per year like clockwork without volatility, investors will feel safe, and safety leads to risk-taking. In a world where stocks are guaranteed to give 8% per year, the logical response from investors would be to keep buying them, till the point where stocks simply become too expensive to continue returning 8%, or where the system becomes too fragile with debt to handle shocks.”

In other words, the fact that stocks are so volatile is why stocks can continue to produce the kind of long-term returns it has done. Investors are put off by the volatility, which causes stocks to be frequently priced to offer premium returns.

Final words

Investing in the stock market is never going to be a smooth journey. Even investing legends have endured huge drawdowns that have resulted in their net worth moving up and down. Warren Buffett, himself, has seen billions wiped out from his net worth in a day. Yet, his ability to accept this pain and invest for the long-term makes him able to reap the long-term benefits of investing in stocks.

Morgan Housel perhaps summed it up best when he wrote: “Accepting a little pain has huge benefits. But it’ll always be rare, because it hurts.”

Disclaimer: The Good Investors is the personal investing blog of two simple guys who are passionate about educating Singaporeans about stock market investing. By using this Site, you specifically agree that none of the information provided constitutes financial, investment, or other professional advice. It is only intended to provide education. Speak with a professional before making important decisions about your money, your professional life, or even your personal life.

HUYA Inc: A Company Riding on Tailwinds of Chinese Gaming

The Chinese Gaming market is expected to grow at double digits for the foreseeable future. HUYA is one company that can capitalise on this booming market.

The Chinese gaming market is expected to grow 14% per year from 2019 to 2024. One company that is likely to benefit from this is HUYA Inc (NYSE: HUYA).

Instead of competing directly with other gaming companies, HUYA Inc is a gaming streaming platform where gaming fans can watch live video game content. It earns money by selling advertising space, and virtual items to users.

The virtuous loop

HUYA is one of two (the other being DouYu) dominant live-game streaming platforms in China. HUYA also hosts eSports events, which are professional e-gaming tournaments.

As a leading player in the game streaming industry in China, HUYA boasts a large network of streamers and viewers. This has resulted in a network effect.

Streamers create content for viewers, which leads to more viewers. The ability to reach a larger audience attracts more streamers to choose HUYA as their streaming platform. More streamers leads to more content for viewers, and round and round the flywheel goes.

Track record of growth

HUYA has demonstrated that it has been able to use its industry-lead to great effect.

The monthly average users on its platform, HUYA Live, grew 28.8% to 150.2 million in the fourth quarter of 2019 compared to the same period a year ago. The number of paying users increased fairly proportionately by 27.6% to 13.4 million. But most impressively, the average spend per paying user increased by a staggering 40.6% to RMB 595.2 in 2019 compared to RMB 423.1 in 2018. 

Putting everything together, HUYA’s revenue from live streaming (virtual gifts) spiked by 79.5% in 2019. Its advertising revenue also saw an 81% increase. The strong growth is nothing new for HUYA as it merely extends its winning streak of growth since 2016. The table below shows HUYA’s total net revenues from 2016 to 2019.

Source: My compilation of data from F-1 and 2019 Annual report

A profitable business model

HUYA’s amazing growth is one thing but, to me, the most important aspect of any business is whether it has cost structures that enable it to turn a profit. HUYA ticks this box. The Chinese live gaming streaming platform was operationally profitable in 2018 and 2019. Margins have also started to widen as HUYA starts to enjoy economies of scale. 

In the first quarter of 2020, HUYA reported an operating profit margin of 5.8% compared to just 1.8% in the same quarter last year.

As HUYA continues to increase its topline, I expect margins to improve substantially as its operating expenses increase much slower than revenue.

Robust balance sheet and positive free cash flow 

As of 31 March 2020, HUYA had no debt, and RMB 10.3 billion (US$1.45 billion) in cash, cash equivalents, restricted cash, short-term deposits, and short-term investments. 

It also generated around RMB 1.9 billion in free cash flow in 2019. It has been producing positive operating cash flow and free cash flow since 2017.

With its strong cash position and the ability to generate cash from its core business, HUYA has the financial muscle to continue spending on expanding its product offering and to grow its user and streamer base.

Strategic owners

Another thing that HUYA has going for it is that Tencent Holdings is its majority shareholder. In April this year, Tencent exercised its option to acquire an additional 16.5% of shares from HUYA’s previous owner, JOYY. After the transfer of shares, JOYY has 43% total voting power, while Tencent Holdings has 50.9% of the voting rights.

Tencent is the world’s largest video gaming company. It owns some of the biggest game developers in the world such as Riot Games, which owns League of Legends. Tencent also has strategic stakes in game developers such as Supercell (the makers of Clash of Clans) and Epic Games (whose platform was used to develop Fortnite).

I think that HUYA can leverage its relationship with Tencent to further consolidate its position as one of the top video game live streaming platforms in China.

Risks

A discussion about any company will not be complete without talking about the risks. As a Chinese company listed in America, the big risk that everyone is talking about is the possibility that Chinese companies may be forced to delist from the US stock market.

On top of that, Chinese companies listed in America do so via American depository receipts (ADRs), which in turn own an interest in a variable interest entity (VIE). This VIE has contractual rights to participate in the economic interests of the actual operating company in China. The structure is really complex, and there could be potential loopholes where certain parties can use to exploit owners of the ADRs. Although this has not been done before for HUYA, there is that possibility that investors need to be aware of. Moreover, if China’s regulatory authorities should deem the VIE contracts to be invalid in the future, owners of the ADRs could be wiped out.

There is execution risk too. HUYA is still a relatively young company and was only listed in 2018. 

In addition, Chinese companies face regulatory risks that could derail its growth. The Chinese government has been known to implement very strict rules on internet companies – that could potentially disrupt HUYA’s business.

Competition is another factor to keep in mind. For now, HUYA enjoys a strong position as one of two big players in this space in China. But things could change if new entrants emerge that somehow have a better platform and are able to attract streamers.

Final Words

I’m keeping an eye on HUYA. It operates in a fast-growing market and I expect to see double-digit growth for at least a few years. In addition, the company is already profitable, has enough cash on its balance sheet for expansion, and has strategic shareholders that it can leverage.

On HUYA’s valuation, the company currently trades at around 3.3 times 2019’s revenue. Based on its current gross margin of around 18% and the potential economies of scale as it grows, I think HUYA can easily settle at a 10% operating margin.

DisclaimerThe Good Investors is the personal investing blog of two simple guys who are passionate about educating Singaporeans about stock market investing. By using this Site, you specifically agree that none of the information provided constitutes financial, investment, or other professional advice. It is only intended to provide education. Speak with a professional before making important decisions about your money, your professional life, or even your personal life.

Can Novocure Revolutionise The Way Cancer is Treated?

Novocure could be changing the way cancer is treated. It sells a wearable device that has been shown to disrupt cancer cell reproduction.

Cancer is a brutal disease and one of the leading causes of death in the developed world. Worldwide, the disease struck more than 17 million people in 2018 with that figure expected to mushroom. 

One company that is doing its part in the fight against cancer is NovoCure Ltd (NASDAQ: NVCR).

Founded in 2000, NovoCure has developed a cancer therapy called tumour treating fields, which inhibits tumour growth and may causes cancer cells to die.

In this article, I take a look at the medical research behind its technology and whether NovoCure is a potential multi-bagger.

Technology behind Novocure

Novocure was founded 20 years ago by Professor Yoram Palti who believed that he could use electric fields to destroy cancer cells.

I don’t want to go too deep into the technicalities but to appreciate Novocure, it is important to understand the basics behind its technology.

In short, cellular proteins in cancer cells need to position themselves in a particular way during cell division in order for cells to divide. Tumour treating fields use alternating electric fields specifically tuned to target cancer cells, disorientating the position of the cell proteins and disrupting cell division.

It is equally important that tumour treating fields also do not stimulate or heat tissues and has minimal damage to healthy cells, with the only side effect being mild to moderate skin irritation.

From theory to practice

Novocure has done an excellent job of turning Professor Palti’s theory into real-life clinical practice. Today, tumour treating fields is approved in certain countries for the treatment of adults with glioblastoma and in the US for mesothelioma. These are two of the most difficult forms of cancer types to treat.

For instance, life expectancy for newly-diagnosed Glioblastoma, the most common type of brain cancer in adults is typically less than two years. 

Today, there is a growing body of research that shows that tumour treating fields therapy can extend the life expectancy of patients when it is used together with other therapies.

The chart from Novocure’s investor presentation shows the survival rate of patients with and without tumour treating fields (Optune) treatment.

Source: Novocure investor presentation 2020

Out of the cohort of 450 patients, 388 received a survival benefit from the use of tumour treating fields. The 5-year survival rate was 13% in the cohort that used tumour treating fields combined with chemotherapy (TMZ or Temozolomide) compared to just 5% in the cohort that used chemotherapy alone.

In fact, the efficacy and minimal side effect of Tumour treating fields as a therapy has led to the National Comprehensive Cancer Network promoting it to a category 1 recommendation for newly diagnosed Glioblastomas,

Growing the number of indications

Tumour treating fields as a therapy could potentially be used on a wide variety of other cancer types. As mentioned earlier, it is FDA approved for (1) recurrent and (2) newly diagnosed glioblastoma and received FDA-approval for (3) Mesothelioma last year.

On top of that, it is undergoing phase III trials for four other indications, namely (1) brain metastasis, (2) non-small cell lung cancer, (3) pancreatic cancer and (4) ovarian cancer. This could significantly increase the company’s addressable market opportunity.

It is also in Phase II trials for liver cancer and preclinical trials for a host of other cancer types. The charts below summarise where the company is at in terms of commercialising its product for the other indications.

Source: Nocovure Investor relations website

Source; Novocure Investor relations website

In its 2019 annual shareholder letter, CEO Asaf Danziger and executive chairman Bill Doyle, reiterated their commitment to innovation saying, 

“We are increasing investments in engineering efforts intended both to improve time on therapy and to maximize the energy delivered to patients’ tumours. Specifically, our teams are working to design and develop improvements to our transducer arrays and to our transducer array layout mapping software intended to increase Tumor Treating Fields intensity and, as a result, survival.

We believe innovation has the potential to improve patient outcomes and to extend our intellectual property protection into the future as we invent enhancements to our products. Our commitment to innovation resulted in 33 new patent applications in 2019, alone.”

From an investors point of view

From a medical standpoint, Novocure’s Tumour Treating Fields technology looks very promising. 

But as investors, we also want to see that the company has the finances to continue funding its research and can drive adoption to grow its revenue.

There are two things I want to see in a promising company like Novocure- (1) a solid balance sheet so that it does not need to raise too much capital to fund its growth and (2) at least some signs that the company is turning its FDA-approval into meaningful revenue growth.

Novocure has both.

The chart below illustrates its net revenues from 2016 to the first quarter of 2020.

Source: Novocure investor presentation 2020

Novocure has also partnered with a Chinese company, Zai, to launch its Tumour treating fields in China. The partnership is already starting to bear fruit with US$2 million in net revenue recorded in greater China in the first quarter of 2020, a 100% increase in from Q4 of 2019.

It is worth noting that Novocure turned operationally and free cash flow positive in 2019. Novocure also has a robust balance sheet with around US$332 million in cash, cash equivalents, short-term investments and restricted cash and no debt. 

Market opportunity

According to Novocure’s S-1 in 2015, Tumour treating fields is broadly applicable to a variety of solid tumours with an annual incidence of 1.1 million people in the United States alone.

Novocure charges around US$21,000 per month for Optune, its tumour treating fields device that is used to treat glioblastomas. Supposing that Novocure sells its other tumour treating fields products at a similar price range, Novocure will have a market opportunity of US$277 billion ($21,000 x 12 months x 1.1million patients) in the United States alone.

That’s of course assuming that Tumour Treating Fields therapy can be FDA-approved for the whole range of applications. 

Valuation

At the time of writing, Novocure had a market cap of US$6.3 billion. On the surface, that seems expensive if you use traditional metrics to value the company. Novocure only had US$351 million in net revenues and US$262 million in gross profits in 2019. 

Based on current share prices, it trades at 17.9 times 2019’s sales and 24 times gross profit. Those numbers are hard to stomach and would certainly be deemed expensive for most companies.

However, Novocure, to me, is not like most companies. 

In the most recent quarter, revenue grew 39% from a year ago. The growth figure could start to accelerate as its core markets mature and Tumour treating fields gains FDA-approval for other indications.

It is also worth remembering that based on my calculations it has a US$277 billion market opportunity. If it can penetrate just 5% of that, its current US$6.7 billion market cap will be a steal.

Final words

Novocure has all the makings of an excellent company. Its technology can potentially be used in a wide array of different indications and is already generating positive free cash flow.

It has a solid track record of growing revenue. Gaining FDA-approval for other use cases could potentially be a catalyst for much greater things for the company. With all that said, it does look like Novocure has all the ingredients for success.

That said, I do acknowledge that as with any biotech firm, there are risks. The risks that it cannot get FDA-approval for other indications or adoption of its product is slower than expected can hinder growth and can lead to other companies catching up with it.

The technology is also very new and widespread adoption will depend on how quickly Novocure can push clinicians to recommend it as a form of treatment. 

But despite these risks, to me, the probability and magnitude of the upside outweigh the risk. With its market cap still small compared to its total addressable market opportunity, I think if it can execute and fulfil its vast potential, Novocure could easily become a multi-bagger based on today’s price.

Disclaimer: The Good Investors is the personal investing blog of two simple guys who are passionate about educating Singaporeans about stock market investing. By using this Site, you specifically agree that none of the information provided constitutes financial, investment, or other professional advice. It is only intended to provide education. Speak with a professional before making important decisions about your money, your professional life, or even your personal life.

How Should We Invest In A Low Interest Rate Environment?

The US benchmark interest rate is back to an all-time low. How should we invest, and what returns can we expect over the long run?

A few months back, the US Federal Reserve slashed its benchmark interest rates to between 0% and 0.25%. The last time it was this low was in late 2008, during the throes of the Great Financial Crisis. Now, with the near-term economic impact of the COVID-19 crisis still unknown, there’s also the possibility that the benchmark interest rate in the US could move into unprecedented negative territory.

This gives us investors a dilemma. In this low rate environment, should we invest in higher-returning but riskier asset classes, or stick to lower-risk but ultra-low-yielding investments?

The search for higher returns

Interest rates are an important determinant in the long-term returns of most asset classes. In a low-interest-rate environment, corporate bonds and treasuries naturally have low yields. Holding cash is an even less attractive proposition, with bank interest rates almost negligible.

In a bid to get higher returns, stocks may be the best option for investors.

How much is enough?

According to Trading Economics, interest rates in the US had averaged at 5.59% from 1971 to 2020. Meanwhile, the S&P 500 returned approximately 9.3% annually during that time. In other words, investors were willing to invest in stocks to make an additional 4% per year more than the risk-free rate.

This makes sense, given that stocks are also more volatile and are considered a riskier asset. Investors, therefore, will require a return-premium to consider investing in stocks.

But interest rates then were much higher than they are today. With the benchmark interest rate in the US now at 0% to 0.25%, what sort of expected returns must the stock market offer to make it an attractive option?

I can’t speak for everyone but considering the options we have, I think that as in the past 50 years, a 4% spread over the risk-free rate makes stocks sufficiently attractive.

The big question

So that naturally leads us to the next question. Can investing in the S&P 500 index at current prices give me a 4% premium over the current risk-free rate.

Sadly, I don’t have the answer to that. The S&P 500 is a basket of 500 stocks that each have their own risk-reward profile. With so many moving parts, it is difficult to quantify how the index will do over the long run. Similarly, other indexes are difficult to predict too.

However, I know that there are individual companies listed in the global stock markets today that could provide an annual expected return of much more than 4% over the risk-free rate.

By carefully building a portfolio out of such stocks, I think investors can navigate safely through the current low-interest environment and still come up with decent returns over the long term.

A few months ago, my blogging partner, Ser Jing, shared his investment framework that helped him build a portfolio of stocks that compounded at a rate that is meaningfully higher than 4% a year (19% to be exact) from October 2010 to May 2020. 

Using a sound investment framework, such as his, to build a portfolio may be all you need to navigate through this low-interest-rate climate.

DisclaimerThe Good Investors is the personal investing blog of two simple guys who are passionate about educating Singaporeans about stock market investing. By using this Site, you specifically agree that none of the information provided constitutes financial, investment, or other professional advice. It is only intended to provide education. Speak with a professional before making important decisions about your money, your professional life, or even your personal life.